GSK-Pfizer deal raises Philippine consumer health competition concerns
GlaxoSmithKline's plan to acquire Pfizer's global consumer healthcare business will undergo in-depth scrutiny after the Philippines' antitrust regulator found indications that it could reduce competition for antitussives and expectorants, analgesics and...To view the full article, register now.
Already a subscriber? Click here to view full article